Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma
dc.contributor.author | Merlos Rodrigo, Miguel Ángel | cs |
dc.contributor.author | Michálková, Hana | cs |
dc.contributor.author | Strmiska, Vladislav | cs |
dc.contributor.author | Casar, Berta | cs |
dc.contributor.author | Crespo, Piero | cs |
dc.contributor.author | De los Rios, Vivian | cs |
dc.contributor.author | Casal Álvarez, José Ignacio | cs |
dc.contributor.author | Haddad, Yazan Abdulmajeed Eyadh | cs |
dc.contributor.author | Guráň, Roman | cs |
dc.contributor.author | Eckschlager, Tomáš | cs |
dc.contributor.author | Pokorná, Petra | cs |
dc.contributor.author | Heger, Zbyněk | cs |
dc.contributor.author | Adam, Vojtěch | cs |
dc.coverage.issue | 1 | cs |
dc.coverage.volume | 11 | cs |
dc.date.accessioned | 2021-05-06T14:55:32Z | |
dc.date.available | 2021-05-06T14:55:32Z | |
dc.date.issued | 2021-03-09 | cs |
dc.description.abstract | Metallothionein-3 has poorly characterized functions in neuroblastoma. Cisplatin-based chemotherapy is a major regimen to treat neuroblastoma, but its clinical efficacy is limited by chemoresistance. We investigated the impact of human metallothionein-3 (hMT3) up-regulation in neuroblastoma cells and the mechanisms underlying the cisplatin-resistance. We confirmed the cisplatin-metallothionein complex formation using mass spectrometry. Overexpression of hMT3 decreased the sensitivity of neuroblastoma UKF-NB-4 cells to cisplatin. We report, for the first time, cisplatin-sensitive human UKF-NB-4 cells remodelled into cisplatin-resistant cells via high and constitutive hMT3 expression in an in vivo model using chick chorioallantoic membrane assay. Comparative proteomic analysis demonstrated that several biological pathways related to apoptosis, transport, proteasome, and cellular stress were involved in cisplatin-resistance in hMT3 overexpressing UKF-NB-4 cells. Overall, our data confirmed that up-regulation of hMT3 positively correlated with increased cisplatin-chemoresistance in neuroblastoma, and a high level of hMT3 could be one of the causes of frequent tumour relapses. | en |
dc.format | text | cs |
dc.format.extent | 1-14 | cs |
dc.format.mimetype | application/pdf | cs |
dc.identifier.citation | Scientific Reports. 2021, vol. 11, issue 1, p. 1-14. | en |
dc.identifier.doi | 10.1038/s41598-021-84185-x | cs |
dc.identifier.issn | 2045-2322 | cs |
dc.identifier.other | 171008 | cs |
dc.identifier.uri | http://hdl.handle.net/11012/196716 | |
dc.language.iso | en | cs |
dc.publisher | Springer Nature | cs |
dc.relation | "European Union (EU)" & "Horizon 2020" | |
dc.relation.ispartof | Scientific Reports | cs |
dc.relation.projectId | info:eu-repo/grantAgreement/EC/H2020/759585/EU//ToMeTuM | |
dc.relation.uri | https://www.nature.com/articles/s41598-021-84185-x | cs |
dc.rights | Creative Commons Attribution 4.0 International | cs |
dc.rights.access | openAccess | cs |
dc.rights.sherpa | http://www.sherpa.ac.uk/romeo/issn/2045-2322/ | cs |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | cs |
dc.subject | Metallothionein-3 | en |
dc.subject | cancer | en |
dc.subject | neuroblastoma | en |
dc.subject | cisplatin | en |
dc.subject | chemoresistance | en |
dc.title | Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma | en |
dc.type.driver | article | en |
dc.type.status | Peer-reviewed | en |
dc.type.version | publishedVersion | en |
sync.item.dbid | VAV-171008 | en |
sync.item.dbtype | VAV | en |
sync.item.insts | 2021.05.06 16:55:32 | en |
sync.item.modts | 2021.05.06 16:14:51 | en |
thesis.grantor | Vysoké učení technické v Brně. Středoevropský technologický institut VUT. Chytré nanonástroje | cs |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Metallothionein3 promotes cisplatin chemoresistance remodelling in neuroblastoma.pdf
- Size:
- 1.91 MB
- Format:
- Adobe Portable Document Format
- Description:
- Metallothionein3 promotes cisplatin chemoresistance remodelling in neuroblastoma.pdf